IDO1 and colorectal carcinoma: Recent evidence has demonstrated that Lactobacillus gallinarum and its derived ICA could improve anti-PD1 efficacy in CRC by associating with the inhibition of the IDO1/Kyn metabolic circuit as well as the antagonism of Kyn binding to AhR receptors on T cells to inhibit Treg differentiation [123,124,125].